NHEJ, nonhomologous end joining; PAM, protospacer surrounding motif; RGN, RNA-guided nuclease
NHEJ, nonhomologous end joining; PAM, protospacer surrounding motif; RGN, RNA-guided nuclease. The cleavage activity of the six RGNs was initially assessed on an episomal reporter plasmid in which thePRKDCorCARD11target sites were cloned between the translational start codon ATG and the open reading frame of a destabilized EGFP (dsEGFP) cassette. 33Upon transfection, GFP expression can be monitored by flow cytometry. safe alternative to SpCas9-based RGNs and hence a valuable option for long term human gene therapy applications. == Intro == Genome engineering using designer nucleases has become increasingly popular for applications ranging from basic research, biotechnology, disease modeling, to human gene therapy. 1Double-strand breaks induced by customized nucleases are harnessed to introduce precise and permanent genetic modifications by activating one of the two main DNA repair mechanisms in the target cells, the error-prone nonhomologous end-joining (NHEJ) pathway, or the accurate homology-directed repair. 2, 3Traditionally, customizable endonucleases based on zinc finger nucleases (ZFNs) or transcriptional activator-like effector nucleases (TALENs) have been used to modify the genomes of several model organisms, including mouse, rat, zebrafish, and monkeys. 4, 5, 6, 7A recent addition to the genome editing toolbox are engineered nucleases based on the clustered regularly interspaced short palindromic replicate (CRISPR)-CRISPR-associated protein 9 (Cas9) system, also known as RNA-guided nucleases (RGNs). 8They are based on the type II CRISPR-Cas9 system of Tafenoquine bacteria and consist of the Cas9 endonuclease protein bound to a dual crRNA: tracrRNA9molecule or a single RNA molecule, the so-called guideline RNA (gRNA). 10, 11, 12Unlike ZFNs and TALENs, which rely on proteinDNA interactions for target site acknowledgement, RGNs hole to their cognate targets by RNADNA base pairing between the ribonucleotide sequence located at the 5-end from the gRNA, thespacer, and the complementary DNA target site, theprotospacer. 13, 14The second element conferring specificity is located immediately downstream from the protospacer. It is referred to asprotospacer adjacent motif(PAM) that is directly recognized by the Cas9 protein. 15, 16, 17The PAM is essential intended for both acquisition of novel spacer sequences into the bacterial CRISPR locus and their orientation within the repeat array. 15If the PAM is not adjacent to a target site, Cas9-mediated cleavage is completely abolished. Cas9 proteins from different species have been isolated, each with Tafenoquine distinct PAM requirements. 18, 19For example, the commonly used Cas9 protein ofStreptococcus pyogenes(SpCas9) recognizes a 5-NGG trinucleotide, while Cas9 of other bacteria, likeStaphylococcus aureus(SaCas9) orNeisseria meningitidis(NmCas9) hole to 5-NNGRRT or 5-NNNNGATT, respectively. 20, 21Interestingly, as compared to SpCas9, these Cas9 proteins are smaller in size although they identify longer PAMs. Given the large size of SpCas9, this aspect has important implications in terms of vectorization from the CRISPR-Cas9 system, as a smaller size allows easier viral packaging. 21 Although SpCas9-based RGNs have been successfully applied in a wide range of organisms and cell types, several Tafenoquine studies have reported high frequencies of off-target mutagenesis, particularly in investigations aimed at developing novel therapeutics intended for human disorders. 22, 23Off-target cleavage can occur at DNA sequences which harbor up to five mismatches compared to the intended target site22; interestingly, most of the off-target sites are mismatched in the 5-end of the target site, 22confirming the previously described knowledge that the 3-end seed sequence is crucial intended for proper interaction of the CRISPR-Cas9 complex and the protospacer. 24, 25A number of improvements possess led to a substantial increase in the fidelity from the SpCas9 system. While truncated gRNAs were shown to reduce the tolerance to mismatched nucleotides, dimeric RGNs, which either consist of two Cas9-based nickases or two catalytically dead Cas9 (dCas9) proteins fused to theFokI nuclease domain, use expanded target sites. 26, 27, 28However, reduced on-target activities of those three systems can be a major drawback. 26 We hypothesized that the PAM is another major determinant of CRISPR-Cas9 specificity. To assay whether a requirement for more stringent PAMs will improve overall specificity in the human being genome, we focused on Cas9 proteins that recognize longer PAM sequences as compared to the SpCas910, 14, 20, 21, such as Cas9 proteins Rabbit Polyclonal to RPS20 derived fromStreptococcus thermophilus(St). St1Cas9 and St3Cas9 are encoded by the StCRISPR1orCRISPR3loci and require 5-NNAGAAW or 5-NGGNG PAMs, respectively. 29, 30Since these PAM sequences are different from the canonical Sp-PAM, StCas9-based Tafenoquine RGNs will even expand the targeting range of the CRISPR-Cas technology. Our results demonstrate that expression of St1Cas9 and St3Cas9 proteins was well tolerated by human being cells. Importantly, the cleavage activities from the StCas9 nucleases at two human loci was comparable to the established SpCas9-based RGNs and similar to previously reported cleavage frequencies for focusing on endogenous human being genes. 10, 31, 32Importantly, as compared to the Sp-derived CRISPR-Cas9 system, the cleavage activities at predicted off-target sites was considerably lower intended for both St1Cas9 and St3Cas9-based RGNs. These St CRISPR-Cas9 systems therefore represent a valid alternative intended for expanding the targeting range of.